Shares in Qiagen and Waters hit 52-week highs this week as their shares closed the 5-day trading period up 5.9 percent and 7.65 percent, respectively. Qiagen reached a year-long high of $16.55 on Tuesday before closing at $16.52, while Waters hit a high of $55.57 before closing Tuesday at $55.05.
Molecular Devices led all gainers in the BCW Index, closing up 9.74 percent for the tracking period. Sequenom led decliners with a drop of 13.24 percent for the week.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.